Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Fidelity

Fidelity Small Cap Growth Fund Fidelity Advisor Small Cap Growth Fund: Class C (FCCGX)

Ticker FCCGX · · Holdings as of Jul 31, 2026

Expense ratio
1.9%$190/yr per $10k
5-yr return
+4.6%annualized
1-yr return
+9.2%as of Sep 2026
Net assets
$8.8Ball share classes
Holdings
365

Bottom line

Is FCCGX a good fund? The bottom line

FCCGX is the Fidelity Advisor Small Cap Growth Fund: Class C share class of Fidelity Small Cap Growth Fund, a managed small-cap mutual fund from Fidelity.

Annual fees run 1.9% — about $190 a year on every $10,000 invested, more expensive than 92% of small-cap funds we track.

It returned +9.2% over one year, +4.6% a year over five years, +11.8% a year over ten (as of Sep 30, 2026, per its prospectus).

With $8.8 billion in net assets and 365 holdings, its largest position is Fidelity Revere Street Trust (4.3%) and the top 10 make up 14.2% of the portfolio.

What stands out

  • Broadly diversified (365 holdings)

What to watch

  • Expensive for its category (1.9%)
  • 5-year return in the bottom quarter of its category
  • 12b-1 marketing fee of 1% a year

Updated Nov 19, 2026

What FCCGX invests in

Fidelity Small Cap Growth Fund seeks capital appreciation.

Normally investing primarily in common stocks. Normally investing at least 80% of assets in securities of growth companies with small market capitalizations. The Adviser generally defines small market capitalization companies as those whose market capitalization is similar to the market capitalization of companies in the Russell 2000 Index or the S&P SmallCap 600 Index. Growth companies are companies the Adviser believes have above average growth potential. The Adviser considers a number of factors in determining a company's growth potential, such as whether the company is included in a third-party growth benchmark or classified as a growth company by a third-party vendor, if the company's projected earnings per share growth, sales growth per share or free cash flow growth or its trailing earnings per share growth is above the equity market median, if the company's research and…

From the fund's prospectus (filed Sep 24, 2026).

FCCGX performance

Average annual total returns
1 yr5 yr10 yr
FCCGX+9.2%+4.6%+11.8%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Sep 30, 2026

Full FCCGX performance history →

What FCCGX costs

On a $10,000 investment, FCCGX's 1.9% expense ratio costs about $190 a year. The prospectus estimates $2,030 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full FCCGX fee table →

FCCGX top 10 holdings

#Holding% of fund
1Fidelity Revere Street Trust4.31%
2Fidelity Revere Street Trust1.70%
3Brightspring Health Services Inc1.36%
4Enova International Inc1.15%
5Cogent Biosciences Inc1.11%
6Interdigital Inc1.03%
7Intapp Inc1.01%
8Rush Street Interactive Inc0.87%
9Spyre Therapeutics Inc0.87%
10Xometry Inc0.84%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 14.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to FCCGX

More funds like FCCGX →

FCCGX FAQ

What is the expense ratio of FCCGX?
FCCGX's expense ratio is 1.9%, which works out to about $190 a year for every $10,000 invested. The prospectus estimates total costs of $2,030 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is FCCGX a good investment?
It depends on your goals, but the data points to: broadly diversified (365 holdings); expensive for its category (1.9%); 5-year return in the bottom quarter of its category; 12b-1 marketing fee of 1% a year. This is general information, not personalized advice.
What does FCCGX hold?
FCCGX's largest holdings are Fidelity Revere Street Trust (4.3%), Fidelity Revere Street Trust (1.7%), Brightspring Health Services Inc (1.4%), Enova International Inc (1.2%), Cogent Biosciences Inc (1.1%). It holds 365 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is FCCGX's 5-year return?
FCCGX returned +4.6% a year over the five years ending Sep 30, 2026, and +11.8% a year over ten years. Past performance does not guarantee future results.
Who manages FCCGX?
FCCGX is offered by Fidelity through Fidelity Securities Fund.